Literature DB >> 26088284

Clinical Translation of Nanomedicine.

Yuanzeng Min1, Joseph M Caster1, Michael J Eblan1, Andrew Z Wang1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26088284      PMCID： PMC4607605          DOI： 10.1021/acs.chemrev.5b00116

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  378 in total

1.  First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.

Authors:  P F Hahn; D D Stark; J M Lewis; S Saini; G Elizondo; R Weissleder; C J Fretz; J T Ferrucci
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

2.  Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes.

Authors:  K Mehta; G Lopez-Berestein; E M Hersh; R L Juliano
Journal:  J Reticuloendothel Soc       Date:  1982-08

3.  Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

Authors:  A N Gordon; J T Fleagle; D Guthrie; D E Parkin; M E Gore; A J Lacave
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

4.  Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.

Authors:  R L Hong; Y L Tseng
Journal:  Cancer       Date:  2001-05-01       Impact factor: 6.860

Review 5.  Anthracycline-related cardiotoxicity in childhood cancer survivors.

Authors:  Steven E Lipshultz; Ruchika Karnik; Peter Sambatakos; Vivian I Franco; Samuel W Ross; Tracie L Miller
Journal:  Curr Opin Cardiol       Date:  2014-01       Impact factor: 2.161

6.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

7.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

Review 9.  Taxol: a novel investigational antimicrotubule agent.

Authors:  E K Rowinsky; L A Cazenave; R C Donehower
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506

10.  Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Authors:  D W Northfelt; B J Dezube; J A Thommes; B J Miller; M A Fischl; A Friedman-Kien; L D Kaplan; C Du Mond; R D Mamelok; D H Henry
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544
View more
  118 in total

1.  Radiolabeled Angiogenesis-Targeting Croconaine Nanoparticles for Trimodality Imaging Guided Photothermal Therapy of Glioma.

Authors:  Longguang Tang; Xiaoli Sun; Nian Liu; Zijian Zhou; Fei Yu; Xianzhong Zhang; Xiaolian Sun; Xiaoyuan Chen
Journal:  ACS Appl Nano Mater       Date:  2018-03-20

2.  Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.

Authors:  Myunggi An; Chunsong Yu; Jingchao Xi; Joyce Reyes; Guangzhao Mao; Wei-Zen Wei; Haipeng Liu
Journal:  Nanoscale       Date:  2018-05-17       Impact factor: 7.790

3.  Targeted nanoparticles for tumour radiotherapy enhancement-the long dawn of a golden era?

Authors:  Elisabetta Gargioni; Florian Schulz; Annette Raabe; Susanne Burdak-Rothkamm; Thorsten Rieckmann; Kai Rothkamm
Journal:  Ann Transl Med       Date:  2016-12

4.  Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo.

Authors:  Yan Wen; Wei Zhang; Ningqiang Gong; Yi-Feng Wang; Hong-Bo Guo; Weisheng Guo; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2017-10-05       Impact factor: 7.790

5.  Set of Highly Stable Amine- and Carboxylate-Terminated Dendronized Au Nanoparticles with Dense Coating and Nontoxic Mixed-Dendronized Form.

Authors:  Arunendra Saha Ray; William E Ghann; Phoebe S Tsoi; Brian Szychowski; Lance T Dockery; Yewon J Pak; Wenjing Li; Maureen A Kane; Peter Swaan; Marie-Christine Daniel
Journal:  Langmuir       Date:  2019-02-18       Impact factor: 3.882

6.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

7.  Diagnostic and Therapeutic Nanomedicine.

Authors:  Jinmyoung Joo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.

Authors:  Anna Lisa Palange; Roberto Palomba; Ilaria F Rizzuti; Miguel Ferreira; Paolo Decuzzi
Journal:  Mol Ther       Date:  2017-03-22       Impact factor: 11.454

Review 9.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

10.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.

Authors:  Miles A Miller; Ravi Chandra; Michael F Cuccarese; Christina Pfirschke; Camilla Engblom; Shawn Stapleton; Utsarga Adhikary; Rainer H Kohler; James F Mohan; Mikael J Pittet; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.